Recital 2, Regulation (EU) 2025/117

In forcesince 24 Jan 2025

Pursuant to Article 16(1) of Regulation (EU) 2021/2282, the Coordination Group is to carry out joint scientific consultations in order to exchange information with health technology developers on their development plans for a medical device or in vitro diagnostic medical device. The aim of such consultations is to facilitate the process of preparing joint clinical assessments for medical devices and in vitro diagnostic medical devices, as they will allow health technology developers to obtain guidance from the Coordination Group on the information, data, analyses and other evidence that are likely to be required from clinical studies for the joint clinical assessment of those devices. Joint scientific consultations can also facilitate the process of preparing relevant updates of joint clinical assessments for medical devices and in vitro diagnostic medical devices when the requests meet the eligibility and selection criteria.